Cargando…
Clinical proteomics for prostate cancer: understanding prostate cancer pathology and protein biomarkers for improved disease management
Following the introduction of routine Prostate Specific Antigen (PSA) screening in the early 1990′s, Prostate Cancer (PCa) is often detected at an early stage. There are also a growing number of treatment options available and so the associated mortality rate is generally low. However, PCa is an ext...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7678104/ https://www.ncbi.nlm.nih.gov/pubmed/33292167 http://dx.doi.org/10.1186/s12014-020-09305-7 |